While to date no unique Pgrn-binding cell surface receptor has been identified [7], [8], recent work by Frampton et al. [23] showed that treatment of cholangiocarcinoma cells with recombinant Pgrn in vitro increased cell proliferation via an Akt-dependent mechanism. The gene discussed is AKT1; the disease is cholangiocarcinoma.